Global Cardiovascular Monitoring and Diagnostic Devices Market Analysis: ECG Systems, Monitors and Forecast to 2020

The global cardiovascular monitoring and diagnostic devices market to reach nearly USD 7.4 Billion by 2020, growing at a CAGR of 9.0% from 2016 to 2020. Diagnosis and monitoring of cardiovascular disorders have become the need for the global healthcare industry in order to prevent the rapid rise in the deaths due to various cardiovascular disorders. Globally rising aging population, incidence of cardiovascular diseases and growing awareness about the risks associated cardiovascular diseases primarily contribute towards the growth of global cardiovascular monitoring and diagnostic devices market.

Browse Cardiovascular Monitoring and Diagnostic Devices Market by Device Types (ECG Systems, Resting ECG Systems, Stress ECG Systems, Cardiovascular Diagnostic Catheters, Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) 2016-2020 at https://www.ihealthcareanalyst.com/report/cardiovascular-monitoring-diagnostic-devices-market/

Cardiovascular monitoring and diagnostics generally refers to continuous monitoring of heart activity, generally by electrocardiography, with assessment of the patient's condition relative to their cardiac rhythm. The Holter monitor is a portable battery-operated device that connects to the patient using bipolar electrodes, providing recordings from up to 12 ECG leads. External event recorders are external devices attached to patients via one to three electrodes with the ability to provide a longer period of monitoring than the standard Holter monitor. They may be patient activated or triggered automatically. Monitoring of the heart rate can be performed as part of electrocardiography, but it can also be measured conveniently with specific heart rate monitors. The implantable cardiac monitor (ICM) has become the investigative tool of choice in recurrent unexplained syncope following negative initial investigations. The ICM permits prolonged monitoring without external electrodes and is ideally suited to patients with infrequent recurrent syncope thought to be due to an arrhythmic cause.

The global cardiovascular monitoring and diagnostic devices market segmentation is based on device or product types (ECG systems, resting ECG systems, stress ECG systems, cardiovascular diagnostic catheters, event monitors, Holter monitors, implantable loop recorders, ECG management systems).

The global cardiovascular monitoring and diagnostic devices market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global cardiovascular monitoring and diagnostic devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiovascular monitoring and diagnostic devices market research report is also segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cardiovascular monitoring and diagnostic devices market and included in this report are Boston Scientific Corporation, Covidien plc, FUKUDA DENSHI Co., Ltd., GE Healthcare, Johnson & Johnson, Medtronic, Inc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Sorin Group, Spacelabs Healthcare, St. Jude Medical, Inc and Welch Allyn, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/cardiovascular-monitoring-diagnostic-devices-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 500-7508
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.